AI News about rapamycin

Large rapamycin clinical trial launches at UT Health San Antonio - UT Health San Antonio

Rapamycin Study Could Transform Aging in Older Adults UT Health San Antonio has launched a major National Institute on Aging-funded clinical trial testing rapamycin, an immunosuppressant drug traditionally used to prevent organ transplant rejection. The study will investigate how rapamycin can promote healthy aging in older adults. This research could unlock new therapeutic applications beyond its current transplant medicine uses.